

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * endocrine pancreas development (GO:0031018) | 7.57865223 |
| 2 | protein maturation by protein folding (GO:0022417) | 7.52032011 |
| 3 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 6.89162861 |
| 4 | glandular epithelial cell differentiation (GO:0002067) | 6.76794718 |
| 5 | peptide hormone processing (GO:0016486) | 6.55648706 |
| 6 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 6.48092980 |
| 7 | COPII vesicle coating (GO:0048208) | 6.37796624 |
| 8 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 6.26787857 |
| 9 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 6.19022159 |
| 10 | exocrine pancreas development (GO:0031017) | 6.05582008 |
| 11 | protein retention in ER lumen (GO:0006621) | 6.00695178 |
| 12 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 5.71068609 |
| 13 | insulin secretion (GO:0030073) | 5.52082280 |
| 14 | positive regulation of nuclease activity (GO:0032075) | 5.44593415 |
| 15 | regulation of nuclease activity (GO:0032069) | 4.96650604 |
| 16 | vesicle coating (GO:0006901) | 4.79727789 |
| 17 | sequestering of metal ion (GO:0051238) | 4.79492719 |
| 18 | negative regulation of norepinephrine secretion (GO:0010700) | 4.78384722 |
| 19 | * type B pancreatic cell development (GO:0003323) | 4.77990165 |
| 20 | signal peptide processing (GO:0006465) | 4.77330518 |
| 21 | dorsal/ventral neural tube patterning (GO:0021904) | 4.75254361 |
| 22 | endoplasmic reticulum unfolded protein response (GO:0030968) | 4.73393984 |
| 23 | neuron fate determination (GO:0048664) | 4.72459530 |
| 24 | nitric oxide mediated signal transduction (GO:0007263) | 4.72040432 |
| 25 | * glandular epithelial cell development (GO:0002068) | 4.69562609 |
| 26 | cellular response to unfolded protein (GO:0034620) | 4.61831929 |
| 27 | * regulation of insulin secretion (GO:0050796) | 4.54600016 |
| 28 | cellular response to vitamin D (GO:0071305) | 4.48254593 |
| 29 | cellular response to topologically incorrect protein (GO:0035967) | 4.45272501 |
| 30 | ER-nucleus signaling pathway (GO:0006984) | 4.44448778 |
| 31 | ER overload response (GO:0006983) | 4.43361278 |
| 32 | * positive regulation of insulin secretion (GO:0032024) | 4.42219687 |
| 33 | ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 4.26284939 |
| 34 | negative regulation of catecholamine secretion (GO:0033604) | 4.18685341 |
| 35 | L-alpha-amino acid transmembrane transport (GO:1902475) | 4.17251215 |
| 36 | epithelial cell fate commitment (GO:0072148) | 4.15519565 |
| 37 | negative regulation of insulin secretion (GO:0046676) | 4.14955891 |
| 38 | * regulation of peptide hormone secretion (GO:0090276) | 4.13120583 |
| 39 | peptide hormone secretion (GO:0030072) | 4.09365466 |
| 40 | * regulation of peptide secretion (GO:0002791) | 4.05748368 |
| 41 | detection of calcium ion (GO:0005513) | 4.05158978 |
| 42 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 4.03278387 |
| 43 | astrocyte differentiation (GO:0048708) | 4.03181021 |
| 44 | peptide secretion (GO:0002790) | 4.01124785 |
| 45 | * columnar/cuboidal epithelial cell development (GO:0002066) | 3.90233714 |
| 46 | negative regulation of calcium ion-dependent exocytosis (GO:0045955) | 3.87870560 |
| 47 | nephron epithelium morphogenesis (GO:0072088) | 3.86415905 |
| 48 | nephron tubule morphogenesis (GO:0072078) | 3.86415905 |
| 49 | neuron fate specification (GO:0048665) | 3.84564104 |
| 50 | neuronal stem cell maintenance (GO:0097150) | 3.83269339 |
| 51 | protein N-linked glycosylation via asparagine (GO:0018279) | 3.81582056 |
| 52 | establishment of nucleus localization (GO:0040023) | 3.79869142 |
| 53 | peptidyl-asparagine modification (GO:0018196) | 3.79574588 |
| 54 | positive regulation of gastrulation (GO:2000543) | 3.79390296 |
| 55 | intra-Golgi vesicle-mediated transport (GO:0006891) | 3.77446225 |
| 56 | response to endoplasmic reticulum stress (GO:0034976) | 3.75568926 |
| 57 | somite rostral/caudal axis specification (GO:0032525) | 3.72809464 |
| 58 | cellular response to hepatocyte growth factor stimulus (GO:0035729) | 3.72647656 |
| 59 | response to hepatocyte growth factor (GO:0035728) | 3.72647656 |
| 60 | toxin metabolic process (GO:0009404) | 3.67568201 |
| 61 | spinal cord motor neuron differentiation (GO:0021522) | 3.66745483 |
| 62 | negative regulation of peptide hormone secretion (GO:0090278) | 3.64042100 |
| 63 | negative regulation of bone resorption (GO:0045779) | 3.58577033 |
| 64 | ER to Golgi vesicle-mediated transport (GO:0006888) | 3.57212113 |
| 65 | * regulation of hormone secretion (GO:0046883) | 3.56974731 |
| 66 | cerebellar Purkinje cell layer development (GO:0021680) | 3.53643609 |
| 67 | response to unfolded protein (GO:0006986) | 3.52620266 |
| 68 | * positive regulation of peptide hormone secretion (GO:0090277) | 3.52117096 |
| 69 | negative regulation of peptide secretion (GO:0002792) | 3.51402643 |
| 70 | intestinal absorption (GO:0050892) | 3.49898735 |
| 71 | protein N-linked glycosylation (GO:0006487) | 3.48802067 |
| 72 | retinal ganglion cell axon guidance (GO:0031290) | 3.47113983 |
| 73 | positive regulation of hormone biosynthetic process (GO:0046886) | 3.44263038 |
| 74 | axonal fasciculation (GO:0007413) | 3.43676766 |
| 75 | nonmotile primary cilium assembly (GO:0035058) | 3.40554596 |
| 76 | response to topologically incorrect protein (GO:0035966) | 3.40394703 |
| 77 | * positive regulation of peptide secretion (GO:0002793) | 3.40392201 |
| 78 | primitive streak formation (GO:0090009) | 3.36315335 |
| 79 | * regulation of peptide transport (GO:0090087) | 3.35499151 |
| 80 | protein localization to Golgi apparatus (GO:0034067) | 3.32634588 |
| 81 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 3.31012709 |
| 82 | inner ear receptor cell development (GO:0060119) | 3.30207014 |
| 83 | cellular response to glucagon stimulus (GO:0071377) | 3.29955425 |
| 84 | hindbrain development (GO:0030902) | 3.29264057 |
| 85 | cranial nerve development (GO:0021545) | 3.28687242 |
| 86 | negative regulation of glycogen biosynthetic process (GO:0045719) | 3.27681051 |
| 87 | cochlea development (GO:0090102) | 3.27045847 |
| 88 | Golgi organization (GO:0007030) | 3.26843987 |
| 89 | dendritic spine morphogenesis (GO:0060997) | 3.25645412 |
| 90 | chemosensory behavior (GO:0007635) | 3.25598471 |
| 91 | intestinal epithelial cell development (GO:0060576) | 3.24397585 |
| 92 | nucleoside diphosphate catabolic process (GO:0009134) | 3.23456335 |
| 93 | negative regulation of mesenchymal cell apoptotic process (GO:2001054) | 3.21453746 |
| 94 | peptide transport (GO:0015833) | 3.20915292 |
| 95 | macroautophagy (GO:0016236) | 3.19529262 |
| 96 | hormone secretion (GO:0046879) | 3.18893023 |
| 97 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.18546526 |
| 98 | intestinal cholesterol absorption (GO:0030299) | 3.18190065 |
| 99 | mesenchyme morphogenesis (GO:0072132) | 3.18164776 |
| 100 | neurofilament cytoskeleton organization (GO:0060052) | 3.15430636 |
| 101 | regulation of hexokinase activity (GO:1903299) | 3.15196604 |
| 102 | regulation of glucokinase activity (GO:0033131) | 3.15196604 |
| 103 | endocardial cushion morphogenesis (GO:0003203) | 3.15157395 |
| 104 | * response to hexose (GO:0009746) | 3.12198993 |
| 105 | dopaminergic neuron differentiation (GO:0071542) | 3.09835156 |
| 106 | * response to glucose (GO:0009749) | 3.09188875 |
| 107 | outer ear morphogenesis (GO:0042473) | 3.08761993 |
| 108 | negative regulation of glial cell proliferation (GO:0060253) | 3.08639716 |
| 109 | ganglion development (GO:0061548) | 3.08036592 |
| 110 | skeletal muscle organ development (GO:0060538) | 3.07152582 |
| 111 | carbohydrate homeostasis (GO:0033500) | 3.05706545 |
| 112 | glucose homeostasis (GO:0042593) | 3.05706545 |
| 113 | regulation of norepinephrine secretion (GO:0014061) | 3.05682894 |
| 114 | regulation of Golgi to plasma membrane protein transport (GO:0042996) | 3.05479236 |
| 115 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.04660034 |
| 116 | regulation of glucocorticoid secretion (GO:2000849) | 3.04073890 |
| 117 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 3.03422661 |
| 118 | axon extension involved in axon guidance (GO:0048846) | 3.03422661 |
| 119 | protein targeting to Golgi (GO:0000042) | 3.01466220 |
| 120 | interleukin-1-mediated signaling pathway (GO:0070498) | 3.01206934 |
| 121 | forebrain neuron differentiation (GO:0021879) | 3.00215466 |
| 122 | negative regulation of glycoprotein metabolic process (GO:1903019) | 3.00118791 |
| 123 | negative regulation of axon guidance (GO:1902668) | 3.00114048 |
| 124 | hormone transport (GO:0009914) | 2.98259644 |
| 125 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 2.97780693 |
| 126 | cellular response to vitamin (GO:0071295) | 2.96340252 |
| 127 | response to dietary excess (GO:0002021) | 2.96222591 |
| 128 | pattern specification involved in kidney development (GO:0061004) | 2.95785803 |
| 129 | renal tubule morphogenesis (GO:0061333) | 2.95547843 |
| 130 | * response to monosaccharide (GO:0034284) | 2.94712539 |
| 131 | response to ischemia (GO:0002931) | 2.92625683 |
| 132 | membrane repolarization during action potential (GO:0086011) | 2.92517062 |
| 133 | negative regulation of oligodendrocyte differentiation (GO:0048715) | 2.92284331 |
| 134 | cellular zinc ion homeostasis (GO:0006882) | 2.91643550 |
| 135 | induction of positive chemotaxis (GO:0050930) | 2.91602531 |
| 136 | positive regulation of steroid biosynthetic process (GO:0010893) | 2.90961909 |
| 137 | viral transcription (GO:0019083) | 2.89760241 |
| 138 | midbrain development (GO:0030901) | 2.89414034 |
| 139 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 2.88254275 |
| 140 | heart valve formation (GO:0003188) | 2.86845052 |
| 141 | presynaptic membrane assembly (GO:0097105) | 2.86012259 |
| 142 | startle response (GO:0001964) | 2.84370758 |
| 143 | cell proliferation involved in metanephros development (GO:0072203) | 2.81952022 |
| 144 | cell differentiation in spinal cord (GO:0021515) | 2.81398095 |
| 145 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.80755603 |
| 146 | translational termination (GO:0006415) | 2.79910994 |
| 147 | regulation of mesenchymal cell apoptotic process (GO:2001053) | 2.77044341 |
| 148 | nodal signaling pathway (GO:0038092) | 2.76722968 |
| 149 | spinal cord development (GO:0021510) | 2.71687760 |
| 150 | kidney morphogenesis (GO:0060993) | 2.71590495 |
| 151 | negative regulation of inclusion body assembly (GO:0090084) | 2.68888317 |
| 152 | negative regulation of axon extension (GO:0030517) | 2.68200955 |
| 153 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 2.68086437 |
| 154 | nucleobase catabolic process (GO:0046113) | 2.67746270 |
| 155 | negative regulation of hormone biosynthetic process (GO:0032353) | 2.64759436 |
| 156 | cotranslational protein targeting to membrane (GO:0006613) | 2.64692472 |
| 157 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 2.62660187 |
| 158 | epithelial to mesenchymal transition involved in endocardial cushion formation (GO:0003198) | 2.62161376 |
| 159 | urinary tract smooth muscle contraction (GO:0014848) | 2.61713879 |
| 160 | regulation of oligodendrocyte differentiation (GO:0048713) | 2.60012338 |
| 161 | protein targeting to ER (GO:0045047) | 2.57104103 |
| 162 | establishment of planar polarity (GO:0001736) | 2.57022967 |
| 163 | establishment of tissue polarity (GO:0007164) | 2.57022967 |
| 164 | retina layer formation (GO:0010842) | 2.55490787 |
| 165 | cell fate specification (GO:0001708) | 2.54815635 |
| 166 | negative regulation of multicellular organism growth (GO:0040015) | 2.54692530 |
| 167 | somite development (GO:0061053) | 2.53366415 |
| 168 | regulation of cardioblast proliferation (GO:0003264) | 2.53074128 |
| 169 | regulation of secondary heart field cardioblast proliferation (GO:0003266) | 2.53074128 |
| 170 | prepulse inhibition (GO:0060134) | 2.52552245 |
| 171 | neuron recognition (GO:0008038) | 2.52348041 |
| 172 | cell proliferation involved in kidney development (GO:0072111) | 2.51040072 |
| 173 | innervation (GO:0060384) | 2.51024399 |
| 174 | diaphragm development (GO:0060539) | 2.50746039 |
| 175 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 2.50410919 |
| 176 | signal transduction involved in regulation of gene expression (GO:0023019) | 2.47512825 |
| 177 | presynaptic membrane organization (GO:0097090) | 2.47233608 |
| 178 | urogenital system development (GO:0001655) | 2.46490400 |
| 179 | positive regulation of embryonic development (GO:0040019) | 2.45783844 |
| 180 | response to auditory stimulus (GO:0010996) | 2.45353189 |
| 181 | glomerulus development (GO:0032835) | 2.45216436 |
| 182 | ectodermal placode formation (GO:0060788) | 2.43199513 |
| 183 | embryonic foregut morphogenesis (GO:0048617) | 2.42831615 |
| 184 | negative regulation of gluconeogenesis (GO:0045721) | 2.41145962 |
| 185 | COPI coating of Golgi vesicle (GO:0048205) | 10.5272285 |
| 186 | Golgi transport vesicle coating (GO:0048200) | 10.5272285 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 9.82262753 |
| 2 | GATA1_22025678_ChIP-Seq_K562_Human | 4.21288286 |
| 3 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 4.11910817 |
| 4 | * CBX2_27304074_Chip-Seq_ESCs_Mouse | 3.90191502 |
| 5 | * EED_16625203_ChIP-ChIP_MESCs_Mouse | 3.34107452 |
| 6 | * JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.01117429 |
| 7 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 3.00932633 |
| 8 | * SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.97822580 |
| 9 | * SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.58679562 |
| 10 | * PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 2.55825274 |
| 11 | * RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 2.55682160 |
| 12 | * RNF2_27304074_Chip-Seq_NSC_Mouse | 2.52519947 |
| 13 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.43391478 |
| 14 | * RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.39183526 |
| 15 | * EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.39183526 |
| 16 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.34595563 |
| 17 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.26314746 |
| 18 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.23946458 |
| 19 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.14526607 |
| 20 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.13855532 |
| 21 | * TP53_20018659_ChIP-ChIP_R1E_Mouse | 2.11837883 |
| 22 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.05130100 |
| 23 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.92827238 |
| 24 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.88878332 |
| 25 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.87985892 |
| 26 | * POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.87022125 |
| 27 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.81459681 |
| 28 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.81265188 |
| 29 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.80588322 |
| 30 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.78571040 |
| 31 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.75030174 |
| 32 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.73213253 |
| 33 | * TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.72767976 |
| 34 | * RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.71035794 |
| 35 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.69138276 |
| 36 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.65046647 |
| 37 | * RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.62282117 |
| 38 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.62180639 |
| 39 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.58612903 |
| 40 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.54965951 |
| 41 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.54492970 |
| 42 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.50417079 |
| 43 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.49150160 |
| 44 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.45461615 |
| 45 | GATA1_19941826_ChIP-Seq_K562_Human | 1.44930441 |
| 46 | REST_19997604_ChIP-ChIP_NEURONS_Mouse | 1.44672310 |
| 47 | FUS_26573619_Chip-Seq_HEK293_Human | 1.44213909 |
| 48 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.42863569 |
| 49 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.40163531 |
| 50 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.39708452 |
| 51 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 1.37767051 |
| 52 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.37214822 |
| 53 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.37214797 |
| 54 | * DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.32525931 |
| 55 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.29391460 |
| 56 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.28736915 |
| 57 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.28313586 |
| 58 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.26298995 |
| 59 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.24988058 |
| 60 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.24392935 |
| 61 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.22748106 |
| 62 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.22492346 |
| 63 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.21329253 |
| 64 | EWS_26573619_Chip-Seq_HEK293_Human | 1.19949490 |
| 65 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.19669225 |
| 66 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.19557322 |
| 67 | VDR_22108803_ChIP-Seq_LS180_Human | 1.18500408 |
| 68 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.18449228 |
| 69 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.17010113 |
| 70 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 1.16815260 |
| 71 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.15732770 |
| 72 | * MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.14707662 |
| 73 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.14638254 |
| 74 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.14504042 |
| 75 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.14281333 |
| 76 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.13942843 |
| 77 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.13238460 |
| 78 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.12499124 |
| 79 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.12467061 |
| 80 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.12467061 |
| 81 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.12310796 |
| 82 | * AR_25329375_ChIP-Seq_VCAP_Human | 1.10974241 |
| 83 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.10238626 |
| 84 | STAT3_23295773_ChIP-Seq_U87_Human | 1.09127123 |
| 85 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.08918222 |
| 86 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.08203988 |
| 87 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.07030360 |
| 88 | * SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 1.06910712 |
| 89 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.06476598 |
| 90 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.05643623 |
| 91 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 1.05459650 |
| 92 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.05405031 |
| 93 | * STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.04698203 |
| 94 | * YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.04078452 |
| 95 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.03202314 |
| 96 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.03095847 |
| 97 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.02049412 |
| 98 | * TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.01601007 |
| 99 | * EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.01594171 |
| 100 | SETDB1_19884257_ChIP-Seq_MESCs_Mouse | 1.01519216 |
| 101 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.00853935 |
| 102 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.00204713 |
| 103 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.99113258 |
| 104 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.98715752 |
| 105 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.98452470 |
| 106 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.97569552 |
| 107 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.97346350 |
| 108 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.97286894 |
| 109 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.97202430 |
| 110 | * NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.97111577 |
| 111 | * BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.95392104 |
| 112 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.94545775 |
| 113 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.94080820 |
| 114 | * ERG_20517297_ChIP-Seq_VCAP_Human | 0.93890567 |
| 115 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.92970642 |
| 116 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.92860652 |
| 117 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.92215093 |
| 118 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.90557075 |
| 119 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 0.90346769 |
| 120 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.90342354 |
| 121 | * JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.90021136 |
| 122 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.89981245 |
| 123 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.89515269 |
| 124 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.89175758 |
| 125 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.89119791 |
| 126 | * RNF2_27304074_Chip-Seq_ESCs_Mouse | 0.87753284 |
| 127 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 0.87273355 |
| 128 | * CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.86552042 |
| 129 | * TBX3_20139965_ChIP-Seq_MESCs_Mouse | 0.86087921 |
| 130 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.85988985 |
| 131 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.85930914 |
| 132 | TBX3_20139965_ChIP-Seq_ESCs_Mouse | 0.85899719 |
| 133 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.85291016 |
| 134 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.85291016 |
| 135 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.84665481 |
| 136 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.84644005 |
| 137 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.83906059 |
| 138 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.83810956 |
| 139 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.83803503 |
| 140 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.83630919 |
| 141 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.83319428 |
| 142 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.83252470 |
| 143 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.83204014 |
| 144 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 0.83053760 |
| 145 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.82970397 |
| 146 | * TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.82233599 |
| 147 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.81937349 |
| 148 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.80578376 |
| 149 | KDM2B_26808549_Chip-Seq_K562_Human | 0.78656723 |
| 150 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.78502264 |
| 151 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.77719746 |
| 152 | * GF1_26923725_Chip-Seq_HPCs_Mouse | 0.77645169 |
| 153 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.76874394 |
| 154 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.76301054 |
| 155 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.76114600 |
| 156 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.75890671 |
| 157 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.75623288 |
| 158 | * AR_19668381_ChIP-Seq_PC3_Human | 0.75487183 |
| 159 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.75304205 |
| 160 | FOXM1_26100407_CHIP-SEQ_Hek293_flp-in_Human | 0.74817834 |
| 161 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.73294018 |
| 162 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.73227655 |
| 163 | TCF4_23295773_ChIP-Seq_U87_Human | 0.70688530 |
| 164 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.70687441 |
| 165 | * GF1B_26923725_Chip-Seq_HPCs_Mouse | 0.70586513 |
| 166 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 0.70536333 |
| 167 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.70170578 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003283_abnormal_digestive_organ | 6.01921152 |
| 2 | MP0002877_abnormal_melanocyte_morpholog | 5.79081746 |
| 3 | * MP0002693_abnormal_pancreas_physiology | 4.57774677 |
| 4 | MP0002909_abnormal_adrenal_gland | 4.48603709 |
| 5 | MP0004043_abnormal_pH_regulation | 4.22238296 |
| 6 | * MP0001944_abnormal_pancreas_morphology | 4.02507194 |
| 7 | MP0009780_abnormal_chondrocyte_physiolo | 3.97208239 |
| 8 | MP0003195_calcinosis | 3.62544873 |
| 9 | MP0000678_abnormal_parathyroid_gland | 3.59248246 |
| 10 | MP0005379_endocrine/exocrine_gland_phen | 3.34497862 |
| 11 | MP0000013_abnormal_adipose_tissue | 3.21457585 |
| 12 | MP0003136_yellow_coat_color | 3.20048420 |
| 13 | MP0010386_abnormal_urinary_bladder | 2.85759243 |
| 14 | MP0005220_abnormal_exocrine_pancreas | 2.81395162 |
| 15 | MP0003183_abnormal_peptide_metabolism | 2.55821276 |
| 16 | MP0002822_catalepsy | 2.49498557 |
| 17 | MP0002078_abnormal_glucose_homeostasis | 2.43000541 |
| 18 | MP0001986_abnormal_taste_sensitivity | 2.38301827 |
| 19 | MP0002653_abnormal_ependyma_morphology | 2.36639186 |
| 20 | MP0002277_abnormal_respiratory_mucosa | 2.29891623 |
| 21 | MP0002234_abnormal_pharynx_morphology | 2.19789936 |
| 22 | MP0002638_abnormal_pupillary_reflex | 2.10470912 |
| 23 | MP0003122_maternal_imprinting | 2.09444244 |
| 24 | MP0002102_abnormal_ear_morphology | 2.04578722 |
| 25 | MP0004264_abnormal_extraembryonic_tissu | 2.02295961 |
| 26 | MP0005646_abnormal_pituitary_gland | 1.98902671 |
| 27 | MP0006072_abnormal_retinal_apoptosis | 1.96396539 |
| 28 | MP0002837_dystrophic_cardiac_calcinosis | 1.96248993 |
| 29 | MP0000778_abnormal_nervous_system | 1.87514510 |
| 30 | MP0000462_abnormal_digestive_system | 1.82663835 |
| 31 | MP0000569_abnormal_digit_pigmentation | 1.81351748 |
| 32 | MP0003868_abnormal_feces_composition | 1.79229499 |
| 33 | MP0000003_abnormal_adipose_tissue | 1.72705665 |
| 34 | MP0002896_abnormal_bone_mineralization | 1.72122567 |
| 35 | MP0004133_heterotaxia | 1.70995272 |
| 36 | MP0003300_gastrointestinal_ulcer | 1.70358769 |
| 37 | MP0002928_abnormal_bile_duct | 1.70202846 |
| 38 | MP0005645_abnormal_hypothalamus_physiol | 1.68438234 |
| 39 | MP0004142_abnormal_muscle_tone | 1.65983653 |
| 40 | MP0008961_abnormal_basal_metabolism | 1.65976906 |
| 41 | MP0002938_white_spotting | 1.65665657 |
| 42 | MP0009379_abnormal_foot_pigmentation | 1.59361961 |
| 43 | MP0000566_synostosis | 1.55296924 |
| 44 | MP0004885_abnormal_endolymph | 1.51624369 |
| 45 | * MP0000955_abnormal_spinal_cord | 1.51573644 |
| 46 | MP0000613_abnormal_salivary_gland | 1.50972279 |
| 47 | MP0008877_abnormal_DNA_methylation | 1.49396465 |
| 48 | MP0003172_abnormal_lysosome_physiology | 1.49066430 |
| 49 | MP0003953_abnormal_hormone_level | 1.47813978 |
| 50 | MP0001765_abnormal_ion_homeostasis | 1.44850716 |
| 51 | MP0005084_abnormal_gallbladder_morpholo | 1.43060666 |
| 52 | MP0009053_abnormal_anal_canal | 1.38663389 |
| 53 | MP0004270_analgesia | 1.36517291 |
| 54 | MP0001529_abnormal_vocalization | 1.35324158 |
| 55 | MP0009046_muscle_twitch | 1.34469209 |
| 56 | MP0002557_abnormal_social/conspecific_i | 1.34141550 |
| 57 | MP0003119_abnormal_digestive_system | 1.32728786 |
| 58 | MP0000631_abnormal_neuroendocrine_gland | 1.31315307 |
| 59 | MP0001486_abnormal_startle_reflex | 1.30087981 |
| 60 | MP0009745_abnormal_behavioral_response | 1.30047444 |
| 61 | MP0000026_abnormal_inner_ear | 1.28381962 |
| 62 | MP0001270_distended_abdomen | 1.25631392 |
| 63 | MP0002572_abnormal_emotion/affect_behav | 1.24468587 |
| 64 | MP0002876_abnormal_thyroid_physiology | 1.20911469 |
| 65 | MP0005257_abnormal_intraocular_pressure | 1.18484098 |
| 66 | MP0002184_abnormal_innervation | 1.18436007 |
| 67 | MP0009643_abnormal_urine_homeostasis | 1.16319873 |
| 68 | MP0002249_abnormal_larynx_morphology | 1.16258348 |
| 69 | MP0003959_abnormal_lean_body | 1.13203702 |
| 70 | MP0001984_abnormal_olfaction | 1.12779465 |
| 71 | MP0002272_abnormal_nervous_system | 1.12010361 |
| 72 | MP0002064_seizures | 1.11371412 |
| 73 | MP0004742_abnormal_vestibular_system | 1.10573981 |
| 74 | MP0003635_abnormal_synaptic_transmissio | 1.09715876 |
| 75 | MP0005503_abnormal_tendon_morphology | 1.09581949 |
| 76 | MP0001485_abnormal_pinna_reflex | 1.09364682 |
| 77 | MP0005535_abnormal_body_temperature | 1.09158257 |
| 78 | MP0006054_spinal_hemorrhage | 1.09014083 |
| 79 | MP0000383_abnormal_hair_follicle | 1.08757764 |
| 80 | MP0004145_abnormal_muscle_electrophysio | 1.08361557 |
| 81 | MP0003938_abnormal_ear_development | 1.06610818 |
| 82 | MP0002063_abnormal_learning/memory/cond | 1.06085238 |
| 83 | MP0005423_abnormal_somatic_nervous | 1.05292477 |
| 84 | MP0006276_abnormal_autonomic_nervous | 1.04966015 |
| 85 | MP0005187_abnormal_penis_morphology | 1.04896756 |
| 86 | MP0003252_abnormal_bile_duct | 1.03646624 |
| 87 | MP0003880_abnormal_central_pattern | 1.02834930 |
| 88 | MP0005310_abnormal_salivary_gland | 1.02592566 |
| 89 | MP0002067_abnormal_sensory_capabilities | 1.02478743 |
| 90 | MP0003942_abnormal_urinary_system | 1.01351968 |
| 91 | MP0000534_abnormal_ureter_morphology | 1.00550798 |
| 92 | MP0000049_abnormal_middle_ear | 1.00293697 |
| 93 | MP0004859_abnormal_synaptic_plasticity | 1.00275331 |
| 94 | MP0005058_abnormal_lysosome_morphology | 0.98137463 |
| 95 | MP0002932_abnormal_joint_morphology | 0.97270240 |
| 96 | MP0002163_abnormal_gland_morphology | 0.95987686 |
| 97 | MP0001286_abnormal_eye_development | 0.95115979 |
| 98 | MP0009250_abnormal_appendicular_skeleto | 0.94670104 |
| 99 | MP0000647_abnormal_sebaceous_gland | 0.94133643 |
| 100 | MP0005386_behavior/neurological_phenoty | 0.93893068 |
| 101 | MP0004924_abnormal_behavior | 0.93893068 |
| 102 | * MP0002882_abnormal_neuron_morphology | 0.93558839 |
| 103 | MP0003011_delayed_dark_adaptation | 0.92203794 |
| 104 | MP0006292_abnormal_olfactory_placode | 0.90958224 |
| 105 | MP0003755_abnormal_palate_morphology | 0.90319347 |
| 106 | MP0003866_abnormal_defecation | 0.90243784 |
| 107 | MP0002697_abnormal_eye_size | 0.89853149 |
| 108 | MP0002735_abnormal_chemical_nociception | 0.89740656 |
| 109 | MP0002233_abnormal_nose_morphology | 0.88420392 |
| 110 | MP0002116_abnormal_craniofacial_bone | 0.87888503 |
| 111 | MP0003787_abnormal_imprinting | 0.87438115 |
| 112 | MP0003861_abnormal_nervous_system | 0.86332184 |
| 113 | MP0002752_abnormal_somatic_nervous | 0.86267446 |
| 114 | MP0009672_abnormal_birth_weight | 0.85108249 |
| 115 | MP0001970_abnormal_pain_threshold | 0.84848101 |
| 116 | MP0005448_abnormal_energy_balance | 0.84358075 |
| 117 | MP0002138_abnormal_hepatobiliary_system | 0.84289068 |
| 118 | MP0001299_abnormal_eye_distance/ | 0.83044335 |
| 119 | MP0001756_abnormal_urination | 0.81517369 |
| 120 | MP0003045_fibrosis | 0.81240181 |
| 121 | MP0001440_abnormal_grooming_behavior | 0.81225521 |
| 122 | MP0003890_abnormal_embryonic-extraembry | 0.81120124 |
| 123 | MP0000230_abnormal_systemic_arterial | 0.81107590 |
| 124 | MP0000681_abnormal_thyroid_gland | 0.79805022 |
| 125 | MP0002152_abnormal_brain_morphology | 0.78267473 |
| 126 | MP0005375_adipose_tissue_phenotype | 0.76981292 |
| 127 | MP0003937_abnormal_limbs/digits/tail_de | 0.75667795 |
| 128 | MP0001666_abnormal_nutrient_absorption | 0.75063533 |
| 129 | MP0005365_abnormal_bile_salt | 0.74862955 |
| 130 | MP0009703_decreased_birth_body | 0.74152835 |
| 131 | MP0005253_abnormal_eye_physiology | 0.73313516 |
| 132 | MP0004134_abnormal_chest_morphology | 0.71932821 |
| 133 | MP0005551_abnormal_eye_electrophysiolog | 0.71121086 |
| 134 | MP0005636_abnormal_mineral_homeostasis | 0.70880992 |
| 135 | MP0000639_abnormal_adrenal_gland | 0.70871776 |
| 136 | MP0010678_abnormal_skin_adnexa | 0.70655887 |
| 137 | MP0001348_abnormal_lacrimal_gland | 0.69502026 |
| 138 | MP0000538_abnormal_urinary_bladder | 0.66604710 |
| 139 | MP0001502_abnormal_circadian_rhythm | 0.66395235 |
| 140 | MP0005248_abnormal_Harderian_gland | 0.65081625 |
| 141 | MP0000428_abnormal_craniofacial_morphol | 0.64493230 |
| 142 | MP0005076_abnormal_cell_differentiation | 0.63043624 |
| 143 | MP0002733_abnormal_thermal_nociception | 0.62029910 |
| 144 | MP0002751_abnormal_autonomic_nervous | 0.60643568 |
| 145 | MP0002069_abnormal_eating/drinking_beha | 0.58798844 |
| 146 | MP0002177_abnormal_outer_ear | 0.58574877 |
| 147 | MP0005670_abnormal_white_adipose | 0.55608735 |
| 148 | MP0005334_abnormal_fat_pad | 0.55334485 |
| 149 | MP0001346_abnormal_lacrimal_gland | 0.55023634 |
| 150 | MP0000470_abnormal_stomach_morphology | 0.54633088 |
| 151 | MP0009642_abnormal_blood_homeostasis | 0.54250058 |
| 152 | MP0001664_abnormal_digestion | 0.53047768 |
| 153 | MP0001731_abnormal_postnatal_growth | 0.52206509 |
| 154 | MP0003795_abnormal_bone_structure | 0.49954878 |
| 155 | MP0003879_abnormal_hair_cell | 0.49597269 |
| 156 | MP0004085_abnormal_heartbeat | 0.49542211 |
| 157 | MP0005083_abnormal_biliary_tract | 0.49504796 |
| 158 | MP0003121_genomic_imprinting | 0.49076441 |
| 159 | MP0002734_abnormal_mechanical_nocicepti | 0.47512086 |
| 160 | MP0000163_abnormal_cartilage_morphology | 0.47432430 |
| 161 | MP0005452_abnormal_adipose_tissue | 0.46644515 |
| 162 | MP0003123_paternal_imprinting | 0.45436000 |
| 163 | MP0005408_hypopigmentation | 0.44363823 |
| 164 | MP0002118_abnormal_lipid_homeostasis | 0.44132687 |
| 165 | MP0002168_other_aberrant_phenotype | 0.43988224 |
| 166 | MP0004036_abnormal_muscle_relaxation | 0.43077704 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hyperinsulinemic hypoglycemia (HP:0000825) | 8.82802205 |
| 2 | Hypoglycemic seizures (HP:0002173) | 7.75647322 |
| 3 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 7.24671028 |
| 4 | Symptomatic seizures (HP:0011145) | 7.08510204 |
| 5 | Hypoglycemic coma (HP:0001325) | 6.49735589 |
| 6 | Insulin-resistant diabetes mellitus (HP:0000831) | 5.98718359 |
| 7 | Pancreatic islet-cell hyperplasia (HP:0004510) | 5.44479710 |
| 8 | Abnormality of endocrine pancreas physiology (HP:0012093) | 5.40197791 |
| 9 | Abnormality of the pancreatic islet cells (HP:0006476) | 5.40197791 |
| 10 | Hyperglycemia (HP:0003074) | 5.36676582 |
| 11 | Large for gestational age (HP:0001520) | 5.03444188 |
| 12 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 4.77778210 |
| 13 | Ketoacidosis (HP:0001993) | 4.59329887 |
| 14 | Late onset (HP:0003584) | 4.49318602 |
| 15 | Decreased circulating renin level (HP:0003351) | 4.41271921 |
| 16 | Abnormal pancreas size (HP:0012094) | 4.36184503 |
| 17 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.96411394 |
| 18 | Mucopolysacchariduria (HP:0008155) | 3.96411394 |
| 19 | Septo-optic dysplasia (HP:0100842) | 3.94220368 |
| 20 | Hypokalemia (HP:0002900) | 3.64535235 |
| 21 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.62418764 |
| 22 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.62418764 |
| 23 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.62418764 |
| 24 | Osteomalacia (HP:0002749) | 3.45906009 |
| 25 | Unilateral renal agenesis (HP:0000122) | 3.45695950 |
| 26 | Dysostosis multiplex (HP:0000943) | 3.43908555 |
| 27 | Insulin resistance (HP:0000855) | 3.43252166 |
| 28 | Maternal diabetes (HP:0009800) | 3.37584857 |
| 29 | Prominent metopic ridge (HP:0005487) | 3.30947381 |
| 30 | Generalized aminoaciduria (HP:0002909) | 3.27537809 |
| 31 | Agitation (HP:0000713) | 3.24847928 |
| 32 | Hyperparathyroidism (HP:0000843) | 3.11795466 |
| 33 | Papilledema (HP:0001085) | 3.10154473 |
| 34 | Abnormality of renin-angiotensin system (HP:0000847) | 3.01519270 |
| 35 | Medial flaring of the eyebrow (HP:0010747) | 2.94591733 |
| 36 | Conjugated hyperbilirubinemia (HP:0002908) | 2.92356566 |
| 37 | Gait imbalance (HP:0002141) | 2.90780597 |
| 38 | Abnormality of the metopic suture (HP:0005556) | 2.87129028 |
| 39 | Gastrointestinal atresia (HP:0002589) | 2.85637023 |
| 40 | Abnormality of potassium homeostasis (HP:0011042) | 2.83403665 |
| 41 | Congenital primary aphakia (HP:0007707) | 2.77392283 |
| 42 | Retinal atrophy (HP:0001105) | 2.73329417 |
| 43 | Abnormality of the intrinsic pathway (HP:0010989) | 2.70014470 |
| 44 | True hermaphroditism (HP:0010459) | 2.66389531 |
| 45 | Bilateral microphthalmos (HP:0007633) | 2.61420424 |
| 46 | Hypsarrhythmia (HP:0002521) | 2.61238936 |
| 47 | EEG with generalized epileptiform discharges (HP:0011198) | 2.59636846 |
| 48 | Esophageal atresia (HP:0002032) | 2.56536791 |
| 49 | Enlarged penis (HP:0000040) | 2.55156797 |
| 50 | Thoracolumbar scoliosis (HP:0002944) | 2.54540996 |
| 51 | Double outlet right ventricle (HP:0001719) | 2.53603936 |
| 52 | Congenital malformation of the right heart (HP:0011723) | 2.53603936 |
| 53 | Congenital, generalized hypertrichosis (HP:0004540) | 2.52168284 |
| 54 | Epileptiform EEG discharges (HP:0011182) | 2.47566628 |
| 55 | Nephrogenic diabetes insipidus (HP:0009806) | 2.44265028 |
| 56 | Hyperactive renin-angiotensin system (HP:0000841) | 2.42740775 |
| 57 | Hyperkalemia (HP:0002153) | 2.42694971 |
| 58 | Congenital glaucoma (HP:0001087) | 2.41504536 |
| 59 | Optic nerve hypoplasia (HP:0000609) | 2.40612988 |
| 60 | Ketosis (HP:0001946) | 2.37297725 |
| 61 | Hemiparesis (HP:0001269) | 2.36722370 |
| 62 | Absent septum pellucidum (HP:0001331) | 2.34681482 |
| 63 | Hypothermia (HP:0002045) | 2.30471004 |
| 64 | Exocrine pancreatic insufficiency (HP:0001738) | 2.29541557 |
| 65 | Abnormal number of incisors (HP:0011064) | 2.29154390 |
| 66 | Poor suck (HP:0002033) | 2.24979843 |
| 67 | Abdominal distention (HP:0003270) | 2.24480224 |
| 68 | Increased circulating renin level (HP:0000848) | 2.23240214 |
| 69 | Hyperphosphatemia (HP:0002905) | 2.19713600 |
| 70 | Hypophosphatemia (HP:0002148) | 2.18672090 |
| 71 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.18128425 |
| 72 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.18128425 |
| 73 | Type I diabetes mellitus (HP:0100651) | 2.17942974 |
| 74 | Nephronophthisis (HP:0000090) | 2.16054389 |
| 75 | Limb hypertonia (HP:0002509) | 2.14629880 |
| 76 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 2.14207550 |
| 77 | Hypoplasia of the fovea (HP:0007750) | 2.14207550 |
| 78 | Limb dystonia (HP:0002451) | 2.11353034 |
| 79 | Cortical visual impairment (HP:0100704) | 2.10946848 |
| 80 | Hyperthyroidism (HP:0000836) | 2.09961726 |
| 81 | Hyperphosphaturia (HP:0003109) | 2.08336946 |
| 82 | Hypercortisolism (HP:0001578) | 2.08047596 |
| 83 | Progressive neurologic deterioration (HP:0002344) | 2.07772651 |
| 84 | Chronic bronchitis (HP:0004469) | 2.06787207 |
| 85 | Restlessness (HP:0000711) | 2.02146724 |
| 86 | Missing ribs (HP:0000921) | 2.01727138 |
| 87 | Molar tooth sign on MRI (HP:0002419) | 2.01467837 |
| 88 | Abnormality of midbrain morphology (HP:0002418) | 2.01467837 |
| 89 | Failure to thrive in infancy (HP:0001531) | 2.00529725 |
| 90 | Abnormality of the 4th metacarpal (HP:0010012) | 2.00424478 |
| 91 | Abnormality of the diencephalon (HP:0010662) | 1.99608205 |
| 92 | Midline defect of the nose (HP:0004122) | 1.99064477 |
| 93 | Ulnar claw (HP:0001178) | 1.98971559 |
| 94 | Occipital encephalocele (HP:0002085) | 1.98773467 |
| 95 | Menstrual irregularities (HP:0000858) | 1.97314223 |
| 96 | Intestinal atresia (HP:0011100) | 1.97060526 |
| 97 | Pancreatic fibrosis (HP:0100732) | 1.96310721 |
| 98 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 1.96023773 |
| 99 | Abnormality of small intestinal villus morphology (HP:0011472) | 1.95386208 |
| 100 | Villous atrophy (HP:0011473) | 1.95386208 |
| 101 | Vaginal atresia (HP:0000148) | 1.94013459 |
| 102 | Dysautonomia (HP:0002459) | 1.93702064 |
| 103 | Poor coordination (HP:0002370) | 1.93487719 |
| 104 | Genital tract atresia (HP:0001827) | 1.93050526 |
| 105 | Skin nodule (HP:0200036) | 1.92704072 |
| 106 | Visual hallucinations (HP:0002367) | 1.92651169 |
| 107 | Abnormal protein glycosylation (HP:0012346) | 1.91870070 |
| 108 | Abnormal glycosylation (HP:0012345) | 1.91870070 |
| 109 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.91870070 |
| 110 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.91870070 |
| 111 | Hypotension (HP:0002615) | 1.90574657 |
| 112 | Abnormality of the fovea (HP:0000493) | 1.90213896 |
| 113 | Macroorchidism (HP:0000053) | 1.88663933 |
| 114 | Pheochromocytoma (HP:0002666) | 1.88150371 |
| 115 | Abnormality of chloride homeostasis (HP:0011422) | 1.86849083 |
| 116 | Sclerocornea (HP:0000647) | 1.84745113 |
| 117 | Prominent supraorbital ridges (HP:0000336) | 1.84273717 |
| 118 | Aplasia/Hypoplasia of the lens (HP:0008063) | 1.84154625 |
| 119 | Severe short stature (HP:0003510) | 1.83406384 |
| 120 | Hypokalemic alkalosis (HP:0001949) | 1.79850601 |
| 121 | Severe muscular hypotonia (HP:0006829) | 1.78954079 |
| 122 | Specific learning disability (HP:0001328) | 1.78726815 |
| 123 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.78521203 |
| 124 | Broad distal phalanx of finger (HP:0009836) | 1.77480740 |
| 125 | Anophthalmia (HP:0000528) | 1.76944856 |
| 126 | Elevated alkaline phosphatase (HP:0003155) | 1.76530487 |
| 127 | Left ventricular hypertrophy (HP:0001712) | 1.76325796 |
| 128 | Protuberant abdomen (HP:0001538) | 1.75724023 |
| 129 | Abnormal sex determination (HP:0012244) | 1.75434431 |
| 130 | Sex reversal (HP:0012245) | 1.75434431 |
| 131 | Pancreatic cysts (HP:0001737) | 1.74264676 |
| 132 | Hemivertebrae (HP:0002937) | 1.72141968 |
| 133 | Adrenal overactivity (HP:0002717) | 1.71117460 |
| 134 | Abnormal urine phosphate concentration (HP:0012599) | 1.70519556 |
| 135 | Abnormality of the common coagulation pathway (HP:0010990) | 1.69281767 |
| 136 | Abnormality of the corticospinal tract (HP:0002492) | 1.69045954 |
| 137 | Cerebellar dysplasia (HP:0007033) | 1.68700494 |
| 138 | Abnormal number of erythroid precursors (HP:0012131) | 1.67925834 |
| 139 | Hypoplastic left heart (HP:0004383) | 1.67520279 |
| 140 | Abnormal respiratory motile cilium physiology (HP:0012261) | 1.66685028 |
| 141 | Irregular vertebral endplates (HP:0003301) | 1.65921603 |
| 142 | Abnormality of the renal medulla (HP:0100957) | 1.65486870 |
| 143 | Shoulder girdle muscle weakness (HP:0003547) | 1.64200928 |
| 144 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.63643521 |
| 145 | Hypoventilation (HP:0002791) | 1.63482398 |
| 146 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.63337848 |
| 147 | Hypomagnesemia (HP:0002917) | 1.63229321 |
| 148 | Type II lissencephaly (HP:0007260) | 1.62728639 |
| 149 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.62412478 |
| 150 | Rib fusion (HP:0000902) | 1.62294132 |
| 151 | Absent eyebrow (HP:0002223) | 1.61879323 |
| 152 | Preaxial foot polydactyly (HP:0001841) | 1.61278515 |
| 153 | Hypogonadotrophic hypogonadism (HP:0000044) | 1.61239037 |
| 154 | Generalized hyperpigmentation (HP:0007440) | 1.60699803 |
| 155 | Downturned corners of mouth (HP:0002714) | 1.60116804 |
| 156 | Glucose intolerance (HP:0000833) | 1.60076220 |
| 157 | Abnormal ciliary motility (HP:0012262) | 1.59730569 |
| 158 | Goiter (HP:0000853) | 1.58433318 |
| 159 | Chorioretinal coloboma (HP:0000567) | 1.58242102 |
| 160 | Muscular hypotonia of the trunk (HP:0008936) | 1.57731490 |
| 161 | Abnormality of the septum pellucidum (HP:0007375) | 1.57594305 |
| 162 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.57519806 |
| 163 | Male pseudohermaphroditism (HP:0000037) | 1.57491992 |
| 164 | Acute necrotizing encephalopathy (HP:0006965) | 1.57398014 |
| 165 | Neoplasm of the heart (HP:0100544) | 1.57130085 |
| 166 | Oligodactyly (hands) (HP:0001180) | 1.56216010 |
| 167 | Metaphyseal irregularity (HP:0003025) | 1.56105394 |
| 168 | Abnormal biliary tract morphology (HP:0012440) | 1.55840799 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | INSRR | 7.87646248 |
| 2 | PASK | 6.32344423 |
| 3 | TAOK3 | 4.44238406 |
| 4 | TSSK6 | 4.12432911 |
| 5 | MAPK15 | 3.72503182 |
| 6 | HIPK2 | 3.53198759 |
| 7 | MAP3K2 | 2.85726704 |
| 8 | PRKD3 | 2.77191720 |
| 9 | MARK1 | 2.44831565 |
| 10 | TAOK1 | 2.28875796 |
| 11 | IRAK3 | 2.28224192 |
| 12 | MAP3K1 | 2.24074613 |
| 13 | CASK | 2.23115671 |
| 14 | ERN1 | 2.12724425 |
| 15 | WEE1 | 2.10131229 |
| 16 | NME1 | 2.09443052 |
| 17 | FRK | 1.94676696 |
| 18 | ADRBK2 | 1.90084994 |
| 19 | FLT3 | 1.82481978 |
| 20 | FGFR2 | 1.81878094 |
| 21 | NTRK3 | 1.79021324 |
| 22 | UHMK1 | 1.78169746 |
| 23 | WNK4 | 1.72833867 |
| 24 | NTRK2 | 1.71716891 |
| 25 | CAMKK2 | 1.69176594 |
| 26 | SCYL2 | 1.63204504 |
| 27 | PDGFRA | 1.59004361 |
| 28 | EPHB2 | 1.53724762 |
| 29 | CDK3 | 1.49030962 |
| 30 | IRAK1 | 1.47237265 |
| 31 | EPHA3 | 1.46161579 |
| 32 | IRAK2 | 1.42629990 |
| 33 | MKNK2 | 1.42447834 |
| 34 | MAP3K4 | 1.41841554 |
| 35 | PRKCG | 1.37834576 |
| 36 | CDC42BPA | 1.35103504 |
| 37 | NTRK1 | 1.34301261 |
| 38 | BRSK2 | 1.29971322 |
| 39 | DYRK1B | 1.27543635 |
| 40 | PRKCH | 1.27224207 |
| 41 | PRKD2 | 1.23957617 |
| 42 | PTK6 | 1.23377795 |
| 43 | TRIB3 | 1.19788756 |
| 44 | DYRK2 | 1.18580737 |
| 45 | PTK2 | 1.17761251 |
| 46 | VRK1 | 1.17638385 |
| 47 | PHKG2 | 1.13679696 |
| 48 | PHKG1 | 1.13679696 |
| 49 | PINK1 | 1.08452880 |
| 50 | DAPK2 | 1.07100824 |
| 51 | TNIK | 1.06863584 |
| 52 | KSR1 | 1.03072664 |
| 53 | MAP2K2 | 1.03059284 |
| 54 | TYRO3 | 1.01122895 |
| 55 | GRK1 | 1.00306997 |
| 56 | IRAK4 | 0.94476425 |
| 57 | TAF1 | 0.91302323 |
| 58 | PAK3 | 0.91279182 |
| 59 | CDK8 | 0.90827601 |
| 60 | MKNK1 | 0.88772810 |
| 61 | YES1 | 0.88179949 |
| 62 | LATS2 | 0.87170931 |
| 63 | EIF2AK3 | 0.85258480 |
| 64 | SIK1 | 0.84569844 |
| 65 | AKT3 | 0.83488953 |
| 66 | LIMK1 | 0.77953606 |
| 67 | BRD4 | 0.76607064 |
| 68 | MAP3K9 | 0.76439084 |
| 69 | STK11 | 0.75875554 |
| 70 | MET | 0.74821020 |
| 71 | MAP3K10 | 0.72259068 |
| 72 | RET | 0.71617600 |
| 73 | JAK2 | 0.70962233 |
| 74 | WNK3 | 0.70267800 |
| 75 | ITK | 0.65266031 |
| 76 | PRKCE | 0.61841017 |
| 77 | NLK | 0.59934905 |
| 78 | MARK2 | 0.59764013 |
| 79 | NEK2 | 0.59711711 |
| 80 | PRKAA1 | 0.57855639 |
| 81 | CAMK1D | 0.57225893 |
| 82 | WNK1 | 0.56657010 |
| 83 | SGK2 | 0.55075741 |
| 84 | CSNK1E | 0.54659107 |
| 85 | PRKCI | 0.52358152 |
| 86 | CSNK1G2 | 0.51429855 |
| 87 | CAMK2A | 0.51252090 |
| 88 | CSNK1G1 | 0.50528480 |
| 89 | RPS6KA2 | 0.48704683 |
| 90 | CAMK2D | 0.48441442 |
| 91 | PRKD1 | 0.47600833 |
| 92 | MINK1 | 0.47409095 |
| 93 | CAMKK1 | 0.45501213 |
| 94 | MAPK13 | 0.44551039 |
| 95 | FER | 0.44489530 |
| 96 | CAMK1G | 0.44201432 |
| 97 | FGFR4 | 0.43072996 |
| 98 | MAP2K7 | 0.42773214 |
| 99 | TGFBR1 | 0.42769767 |
| 100 | GSK3A | 0.42666941 |
| 101 | BRSK1 | 0.42343727 |
| 102 | JAK1 | 0.42172758 |
| 103 | EPHA4 | 0.42039798 |
| 104 | STK38L | 0.41862151 |
| 105 | PLK3 | 0.40833280 |
| 106 | BRAF | 0.40572395 |
| 107 | PRKACG | 0.39996189 |
| 108 | ADRBK1 | 0.39751716 |
| 109 | CSNK1G3 | 0.39516025 |
| 110 | ALK | 0.39147954 |
| 111 | FGFR3 | 0.38367138 |
| 112 | LATS1 | 0.37390678 |
| 113 | BCR | 0.35587478 |
| 114 | PRKG1 | 0.35552239 |
| 115 | CSNK1A1 | 0.35330655 |
| 116 | MAP3K3 | 0.34166489 |
| 117 | PAK2 | 0.33144352 |
| 118 | IGF1R | 0.32780427 |
| 119 | PDGFRB | 0.32289772 |
| 120 | PRKACA | 0.32247787 |
| 121 | CAMK2B | 0.31813444 |
| 122 | EPHB1 | 0.31376858 |
| 123 | CHUK | 0.30620181 |
| 124 | LMTK2 | 0.30586489 |
| 125 | PRKCZ | 0.30414178 |
| 126 | CDK5 | 0.30188687 |
| 127 | RPS6KB1 | 0.29159257 |
| 128 | MAPK14 | 0.29151322 |
| 129 | PRKDC | 0.28982667 |
| 130 | TEC | 0.28276263 |
| 131 | MTOR | 0.28203498 |
| 132 | BTK | 0.27861810 |
| 133 | RPS6KA6 | 0.26059051 |
| 134 | JAK3 | 0.25645938 |
| 135 | BMPR1B | 0.25625080 |
| 136 | NEK6 | 0.25468732 |
| 137 | DYRK1A | 0.25417739 |
| 138 | BCKDK | 0.24129033 |
| 139 | STK4 | 0.23968040 |
| 140 | PRKACB | 0.23902876 |
| 141 | MAP2K6 | 0.23788750 |
| 142 | PNCK | 0.22554698 |
| 143 | DYRK3 | 0.21865682 |
| 144 | SGK1 | 0.21812946 |
| 145 | CSNK2A2 | 0.21041360 |
| 146 | GRK5 | 0.20917293 |
| 147 | ZAP70 | 0.20132719 |
| 148 | KSR2 | 0.19379954 |
| 149 | AKT1 | 0.18933873 |
| 150 | MAP2K1 | 0.18383620 |
| 151 | PRKCA | 0.17989163 |
| 152 | RPS6KA5 | 0.17911235 |
| 153 | PLK2 | 0.17675491 |
| 154 | PIK3CG | 0.17409702 |
| 155 | MAPK9 | 0.17366037 |
| 156 | NUAK1 | 0.16943007 |
| 157 | MAP2K4 | 0.16675458 |
| 158 | CSNK1A1L | 0.16599415 |
| 159 | SGK223 | 0.16560651 |
| 160 | SGK494 | 0.16560651 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 9.50852074 |
| 2 | Protein export_Homo sapiens_hsa03060 | 5.17569955 |
| 3 | Insulin secretion_Homo sapiens_hsa04911 | 3.43496463 |
| 4 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 3.22980967 |
| 5 | Sulfur metabolism_Homo sapiens_hsa00920 | 3.01703326 |
| 6 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 2.89398265 |
| 7 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.72129217 |
| 8 | Ribosome_Homo sapiens_hsa03010 | 2.53767165 |
| 9 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.38244383 |
| 10 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 2.36555457 |
| 11 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.01846847 |
| 12 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 2.01464271 |
| 13 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.92466580 |
| 14 | Nicotine addiction_Homo sapiens_hsa05033 | 1.86495869 |
| 15 | Parkinsons disease_Homo sapiens_hsa05012 | 1.84141607 |
| 16 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.82351979 |
| 17 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.73055293 |
| 18 | Cocaine addiction_Homo sapiens_hsa05030 | 1.70796036 |
| 19 | Basal cell carcinoma_Homo sapiens_hsa05217 | 1.67919508 |
| 20 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.59174667 |
| 21 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.56152570 |
| 22 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.48473270 |
| 23 | Lysosome_Homo sapiens_hsa04142 | 1.38352465 |
| 24 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.35758677 |
| 25 | Taste transduction_Homo sapiens_hsa04742 | 1.29068501 |
| 26 | Alzheimers disease_Homo sapiens_hsa05010 | 1.28723774 |
| 27 | Axon guidance_Homo sapiens_hsa04360 | 1.21970099 |
| 28 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.20753679 |
| 29 | Huntingtons disease_Homo sapiens_hsa05016 | 1.20517096 |
| 30 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.18797904 |
| 31 | Phototransduction_Homo sapiens_hsa04744 | 1.16746779 |
| 32 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.09311869 |
| 33 | Insulin resistance_Homo sapiens_hsa04931 | 1.07738281 |
| 34 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.05487554 |
| 35 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.02169639 |
| 36 | Hippo signaling pathway_Homo sapiens_hsa04390 | 1.01394133 |
| 37 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 1.01212756 |
| 38 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.01145849 |
| 39 | Circadian rhythm_Homo sapiens_hsa04710 | 0.99854066 |
| 40 | Other glycan degradation_Homo sapiens_hsa00511 | 0.99336072 |
| 41 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.98623216 |
| 42 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.97827775 |
| 43 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.97534970 |
| 44 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.95955247 |
| 45 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.94512377 |
| 46 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.94442348 |
| 47 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.92964863 |
| 48 | ABC transporters_Homo sapiens_hsa02010 | 0.88837284 |
| 49 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.88522206 |
| 50 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.85625402 |
| 51 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.85043047 |
| 52 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.83873594 |
| 53 | Long-term potentiation_Homo sapiens_hsa04720 | 0.83437977 |
| 54 | Prion diseases_Homo sapiens_hsa05020 | 0.78870202 |
| 55 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.78632985 |
| 56 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.76000727 |
| 57 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.74735007 |
| 58 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.74241783 |
| 59 | RNA polymerase_Homo sapiens_hsa03020 | 0.73804986 |
| 60 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.73581604 |
| 61 | Circadian entrainment_Homo sapiens_hsa04713 | 0.73092622 |
| 62 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.70704631 |
| 63 | GABAergic synapse_Homo sapiens_hsa04727 | 0.68281688 |
| 64 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.66495196 |
| 65 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.65583282 |
| 66 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.65351568 |
| 67 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.64633748 |
| 68 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.64050635 |
| 69 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.62931265 |
| 70 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.61946736 |
| 71 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.61636899 |
| 72 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.59282058 |
| 73 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.56667545 |
| 74 | Galactose metabolism_Homo sapiens_hsa00052 | 0.56468401 |
| 75 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.55921996 |
| 76 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.55821330 |
| 77 | Bile secretion_Homo sapiens_hsa04976 | 0.55742227 |
| 78 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.55251862 |
| 79 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.55097659 |
| 80 | Alcoholism_Homo sapiens_hsa05034 | 0.54716623 |
| 81 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.53219449 |
| 82 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.52781989 |
| 83 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.52550779 |
| 84 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.52476545 |
| 85 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.52448949 |
| 86 | Salivary secretion_Homo sapiens_hsa04970 | 0.51129596 |
| 87 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.50813277 |
| 88 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.49483868 |
| 89 | Renin secretion_Homo sapiens_hsa04924 | 0.48600049 |
| 90 | Thyroid cancer_Homo sapiens_hsa05216 | 0.47955414 |
| 91 | Basal transcription factors_Homo sapiens_hsa03022 | 0.47699395 |
| 92 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.46647302 |
| 93 | Morphine addiction_Homo sapiens_hsa05032 | 0.46308458 |
| 94 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.45110082 |
| 95 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.44202478 |
| 96 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.41946369 |
| 97 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.41547874 |
| 98 | Prostate cancer_Homo sapiens_hsa05215 | 0.41390945 |
| 99 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.41238612 |
| 100 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.40554140 |
| 101 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.40302690 |
| 102 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.40174513 |
| 103 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.38847213 |
| 104 | Melanogenesis_Homo sapiens_hsa04916 | 0.38530779 |
| 105 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.37899295 |
| 106 | Gap junction_Homo sapiens_hsa04540 | 0.37898174 |
| 107 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.37373699 |
| 108 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.36714039 |
| 109 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.36435412 |
| 110 | Lysine degradation_Homo sapiens_hsa00310 | 0.35774608 |
| 111 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.35321064 |
| 112 | Spliceosome_Homo sapiens_hsa03040 | 0.34994471 |
| 113 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.33888376 |
| 114 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.33782019 |
| 115 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.33719716 |
| 116 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.33354331 |
| 117 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.32206858 |
| 118 | Bladder cancer_Homo sapiens_hsa05219 | 0.31806270 |
| 119 | Olfactory transduction_Homo sapiens_hsa04740 | 0.31486355 |
| 120 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.31271058 |
| 121 | Mineral absorption_Homo sapiens_hsa04978 | 0.31013714 |
| 122 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.30869265 |
| 123 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.30704008 |
| 124 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.29690768 |
| 125 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.29246817 |
| 126 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.29030105 |
| 127 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.28614841 |
| 128 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.27323710 |
| 129 | Endometrial cancer_Homo sapiens_hsa05213 | 0.26571855 |
| 130 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.25458066 |
| 131 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.21827432 |
| 132 | Long-term depression_Homo sapiens_hsa04730 | 0.21785958 |
| 133 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.21648990 |
| 134 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.20133095 |
| 135 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.18685351 |
| 136 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.17848883 |
| 137 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.17714740 |
| 138 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.17419896 |
| 139 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.15861258 |
| 140 | Glioma_Homo sapiens_hsa05214 | 0.11646149 |
| 141 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.10979882 |
| 142 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.10758727 |

